Targeting the IL-23 Receptor Gene: A Promising Approach in Inflammatory Bowel Disease Treatment

Abstract excerpt

Inflammatory bowel disease (IBD), which includes Crohn’s Disease (CD) and ulcerative colitis (UC), is characterized by chronic inflammation of the gastrointestinal tract. A key component of the inflammatory pathway in IBD is interleukin 23 (IL-23), which promotes the differentiation and maintenance of Th17 cells. These cells are major contributors to intestinal inflammation and the release of pro-inflammatory...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Inflammatory Bowel Disease
• Share to Microscopic Colitis
• Share to Psoriasis: Treatment and Pathogenesis